Medication after unilateral surgery for thyroid cancer

Thyroid cancer is a common endocrine tumor in clinical practice. After unilateral surgery, patients with thyroid cancer need to use drugs for auxiliary treatment, mainly including levothyroxine sodium tablets, thyroid tablets, furosemide tablets, compound iodine solution, calcium carbonate tablets, etc.

1. Levothyroxine Sodium Tablets: Patients with thyroid cancer after surgery usually need to take Levothyroxine Sodium Tablets to supplement thyroid hormones and inhibit the secretion of thyroid-stimulating hormone, thereby reducing the chance of recurrence of thyroid cancer;

2. Thyroid tablets: Thyroid tablets are a type of drug that supplements thyroid hormone and can be used for supplementary treatment of thyroid cancer patients after surgery;

3. Furosemide tablets: Furosemide tablets can reduce the content of thyroxine in the blood through diuretic effect, and excrete harmful substances from the body as soon as possible by accelerating the body's metabolism, so as to reduce the chance of postoperative complications;

4. Compound iodine solution: Thyroid cancer patients may experience inflammation of the tissues surrounding the thyroid gland after surgery. Compound iodine solution can be used for disinfection and applied externally to the swollen area, which has the effects of reducing swelling, dispersing nodules, and relieving pain.

5. Calcium carbonate tablets: If thyroid cancer patients undergo unilateral thyroidectomy, it may lead to insufficient calcium intake and symptoms such as osteoporosis. At this time, calcium carbonate tablets can be taken to supplement calcium in the body and relieve osteoporosis.

In addition to the above drugs, patients can also use other drugs for auxiliary treatment, such as alendronate sodium tablets. Patients with thyroid cancer should have regular color Doppler ultrasound examinations after surgery to determine whether the tumor recurs or metastasizes. If tumor recurrence is found, surgical treatment can be taken in time to avoid the tumor from developing to the late stage and distant metastasis, which will affect the patient's life span.